ipamorelin ghrelin receptor agonist growth hormone releasing peptide Comment “curious” for the full newsletter. 👇 The universe of muscle-building peptides and related compounds is confusing as heck. It's a sea of scientific jargon—CJC-1295, ipamorelin, tesamorelin, sermorelin, MK-677… Today's letter, explains Sleep & Sculpt Peptide Therapy

Therefore, the discrepancy of the histological results obtained in acromegalic animals and humans may be, at least partly, due to significantly more pronounced GH excess in animals compared to humans

The structural modifications incorporated into CJC-1295 include D-alanine at position 2 to enhance resistance to enzymatic degradation, glutamine at position 8 to reduce asparagine rearrangement and prevent amide hydrolysis to aspartic acid, alanine at position 15 to enhance bioactivity, and leucine at position 27 to prevent methionine oxidation

Ipamorelin While both peptides promote growth hormone release , their mechanisms differ significantly

A common starting point is 100 mcg CJC-1295 (no DAC) plus 100 mcg Ipamorelin

McGraw-Hill / Lange Reilly RF, Jackson (2011): Regulation of Renal Function and Vascular Volume (Chapter 25)

All of the theoretical concerns are not currently supported by the existing evidence available to us